A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tenamfetamine
Tedizolid phosphate
The risk or severity of bleeding can be increased when Betrixaban is combined with Tedizolid phosphate.
Tenamfetamine
Tofacitinib
The risk or severity of bleeding can be increased when Betrixaban is combined with Tofacitinib.
Tenamfetamine
Ruxolitinib
The risk or severity of bleeding can be increased when Betrixaban is combined with Ruxolitinib.
Tenamfetamine
Eribulin
The risk or severity of bleeding can be increased when Betrixaban is combined with Eribulin.
Tenamfetamine
Human interferon omega-1
The risk or severity of bleeding can be increased when Betrixaban is combined with Human interferon omega-1.
Tenamfetamine
Interferon alfa
The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa.
Tenamfetamine
Trabectedin
The risk or severity of bleeding can be increased when Betrixaban is combined with Trabectedin.
Tenamfetamine
Thiotepa
The risk or severity of bleeding can be increased when Betrixaban is combined with Thiotepa.
Tenamfetamine
Vorinostat
The risk or severity of bleeding can be increased when Betrixaban is combined with Vorinostat.
Tenamfetamine
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Betrixaban.
Tenamfetamine
Monteplase
The risk or severity of bleeding can be increased when Betrixaban is combined with Monteplase.
Tenamfetamine
Semuloparin
The risk or severity of bleeding can be increased when Betrixaban is combined with Semuloparin.
Tenamfetamine
Dabigatran
The risk or severity of bleeding can be increased when Betrixaban is combined with Dabigatran.
Tenamfetamine
Coumarin
The risk or severity of bleeding can be increased when Betrixaban is combined with Coumarin.
Tenamfetamine
Antithrombin Alfa
The risk or severity of bleeding can be increased when Betrixaban is combined with Antithrombin Alfa.
Tenamfetamine
Zinc citrate
The risk or severity of bleeding can be increased when Betrixaban is combined with Zinc citrate.
Tenamfetamine
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Betrixaban is combined with Edetate calcium disodium anhydrous.
Tenamfetamine
(S)-Warfarin
The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Betrixaban.
Tenamfetamine
(R)-warfarin
The risk or severity of bleeding can be increased when (R)-warfarin is combined with Betrixaban.
Tenamfetamine
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Betrixaban.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3